Medigus

$1.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+1.20%) Today
-$0.02 (-1.18%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Medigus and other stocks, options, and ETFs commission-free!

About MDGS

Medigus Ltd. engages in research and development of medical treatment for the gastrointestinal tract. Its product is the MUSE system, an endoscopic device to perform Transoral Fundoplication for the treatment of gastroesophageal reflux disease.

CEO
Liron Carmel
Employees
20
Headquarters
Omer, HaDarom
Founded
1999
Market Cap
56.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
726.05K
High Today
$1.73
Low Today
$1.57
Open Price
$1.63
Volume
1.25M
52 Week High
$5.15
52 Week Low
$1.16

You May Also Like

LPL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure